What is he best known for?
The fields of study he is best known for:
Peter Devilee mainly investigates Breast cancer, Genetics, Cancer, Internal medicine and Genome-wide association study.
His study in Breast cancer is interdisciplinary in nature, drawing from both Cancer research, Single-nucleotide polymorphism, Genotype and Genetic predisposition.
His studies deal with areas such as Mutation, RNA and PALB2 as well as Cancer.
His Internal medicine research includes elements of Endocrinology and Oncology.
He interconnects Mendelian randomization, Bioinformatics, Disease, Genetic association and 1000 Genomes Project in the investigation of issues within Genome-wide association study.
His Allele research is multidisciplinary, relying on both Genetic marker, Molecular biology and DNA.
His most cited work include:
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families (2565 citations)
- Mutations in the p53 gene occur in diverse human tumour types (2385 citations)
- Pathology and Genetics of Tumours of the Breast and Female Genital Organs (2316 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Breast cancer, Genetics, Internal medicine, Oncology and Cancer.
His biological study spans a wide range of topics, including Cancer research, Genome-wide association study, Genotype, Single-nucleotide polymorphism and Ovarian cancer.
His Genome-wide association study study combines topics in areas such as Genetic association and Bioinformatics.
Genetics is represented through his Allele, Gene, Locus, Germline mutation and Haplotype research.
His Internal medicine study frequently draws connections between adjacent fields such as Pathology.
He combines subjects such as Genetic predisposition, Case-control study, Gynecology, Prospective cohort study and Risk factor with his study of Oncology.
He most often published in these fields:
- Breast cancer (56.71%)
- Genetics (43.06%)
- Internal medicine (32.41%)
What were the highlights of his more recent work (between 2013-2021)?
- Breast cancer (56.71%)
- Genetics (43.06%)
- Internal medicine (32.41%)
In recent papers he was focusing on the following fields of study:
Peter Devilee spends much of his time researching Breast cancer, Genetics, Internal medicine, Oncology and Genome-wide association study.
The Breast cancer study combines topics in areas such as Single-nucleotide polymorphism, Genetic association, Genotype and Bioinformatics.
His Genetics research focuses on subjects like Paraganglioma, which are linked to SDHB and Pheochromocytoma.
Internal medicine is a component of his Hazard ratio, Ovarian cancer, Cancer, Proportional hazards model and Family history studies.
His study on Oncology also encompasses disciplines like
- Odds ratio that connect with fields like Gynecology and Risk factor,
- Prospective cohort study which is related to area like Mendelian randomization.
His Genome-wide association study study combines topics from a wide range of disciplines, such as Genetic predisposition, Case-control study, Quantitative trait locus, Genotyping and Locus.
Between 2013 and 2021, his most popular works were:
- MicroRNA related polymorphisms and breast cancer risk (582 citations)
- Association analysis identifies 65 new breast cancer risk loci (569 citations)
- Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk (518 citations)
In his most recent research, the most cited papers focused on:
Peter Devilee mainly focuses on Breast cancer, Genome-wide association study, Genetics, Internal medicine and Oncology.
Breast cancer is a subfield of Cancer that Peter Devilee explores.
His Genome-wide association study study incorporates themes from Mendelian randomization, Genetic predisposition, Locus and 1000 Genomes Project.
As a part of the same scientific study, Peter Devilee usually deals with the Genetics, concentrating on Menarche and frequently concerns with Genomic imprinting, Genetic architecture, Polymorphism, Population variance and Heritability.
In his study, Methylation, Histone methylation, Epigenetics and Histone is inextricably linked to Pathology, which falls within the broad field of Internal medicine.
His Oncology study integrates concerns from other disciplines, such as Relative risk, Gynecology, Ovarian cancer, Hazard ratio and Family history.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
